Argentina Traceability System versus UDI: Two Systems Compared

1. Key takeaways

Argentina recommends UDI, but its current system is a medical products traceability system, and UDI is not the traceability system. The two share technical common ground, since both adopt GS1 standards, but in legal nature, scope of application, and data structure they are two distinct systems. Treating them as interchangeable is the most consequential planning error a manufacturer can make here: compliance work designed for one framework does not automatically discharge obligations under the other, and assuming equivalence either wastes effort or leaves real duties unmet.

The comparison above has a direct budgeting implication. Companies holding UDI compliance in other markets inherit the product-coding layer of the Argentine system almost entirely, since GS1-based GTINs and a serial number scheme within 20 characters carry over. What they do not inherit is the reporting layer: the GLN for their entities, the logistics flow information, and the operational linkage of shipments to product codes. Preparation cost therefore concentrates in the reporting workstream, and the earlier it is scoped together with local warehousing and distribution partners, the smaller the risk to launch timelines.

2. Legal basis

3. Expert insights

Insight 1: The Argentine system adds a layer of logistics flow information on top of UDI. UDI asks what this product is; the Argentine system, beyond product identification, requires real-time reporting of the recipient code (GLN/CUFE), dates, invoices, and delivery notes. This is a traceability design covering the full chain of distribution, delivery, and use, and its reporting frequency and assigned responsibilities are both heavier than in a pure UDI regime. Every movement of goods in the Argentine channel generates reportable data, which means the system touches warehouse operations, distributor relationships, and billing documents, not merely labeling and database submission.

Insight 2: The gap in scope of application is the main variable in preparation cost. UDI in the Chinese mainland and the EU proceeds in batches by risk class and covers broadly; Argentine phase one covers only eight categories of implantable devices. For products outside these eight categories, companies currently need not adapt coding to the Argentine system, but they should preserve expansion capability, for example by reserving a serial number scheme within 20 characters. Scope today is not scope tomorrow: the closed list is the kind of instrument regulators extend, and retrofitting coding infrastructure after an expansion announcement is far more expensive than keeping the option open.

Insight 3: GS1 standards are the largest common denominator and can be reused. For companies that have already assigned GTINs under GS1 standards, the product-side coding can connect directly to the Argentine system; the serial number limit of 20 alphanumeric characters is the main constraint to check. The main incremental work lies in the GLN application and the logistics information reporting process, and this is the part that can be prepared in advance. In other words, global GS1 investment made for other markets retains its value in Argentina; only the Argentina-specific reporting layer must be built new.

Insight 4: The two systems also differ in who reads the data. A UDI database primarily supports identification: regulators, hospitals, and patients can establish what a given product is. The Argentine traceability system, by design, supports surveillance of movement: ANMAT can follow a specific unit from importation through distribution to the receiving facility. This difference in purpose explains the difference in reported content, and it also explains why the Argentine system cannot be satisfied by submitting product identification data alone. A company planning only for identification will pass the coding checks and fail the operational ones, because the missing element is not a code but a process, namely the routine reporting of every logistics event against the product codes it moves.

4. Practical recommendations

1. Do not infer Argentine obligations directly from UDI compliance conclusions in the Chinese mainland or the EU. Assess the two systems separately: first check whether the product is on the eight-category list, then prepare according to the Argentine rules.
2. Reuse the GTIN and add the GLN. The product-side GTIN can follow the global unified coding; for the entity side, a GLN must be applied for separately from GS1 Argentina.
3. Design the logistics information reporting process. Define who reports, when, and which fields, and align with the local warehousing and distribution partners.
4. Track the expansion of the list. The phase one list may be extended, so implantable product lines should remain under active tracking.

5. Verification checklist

• □ It has been made clear that the Argentine traceability system and UDI are two separate systems
• □ Products have been checked against the eight-category implantable device list
• □ GTINs have been assigned under GS1 and can be reused
• □ A GLN has been applied for from GS1 Argentina
• □ A reporting process for logistics information, namely GLN/CUFE, dates, invoices, and delivery notes, has been designed
• □ A tracking mechanism for expansion of the phase one list has been established

Regulatory information verified as of October 29, 2026.

In Argentina, GRZAN operates a wholly owned subsidiary that can act as the registration holder and importer for foreign manufacturers, directly handling classification assessment, pathway selection, GMP and CFS documentation chains, Spanish-language technical documentation and label localization, HELENA submissions and deficiency responses, as well as BONITA import notifications, ARGOS vigilance system operation, change maintenance, and 5-year renewal planning.

The GRZAN regulatory team consists of professionals with many years of hands-on international registration experience, tracking the developments of regulators worldwide. All external content follows the drafting standard of conclusions first, traceable basis, and verifiable numbers. For a market access plan tailored to your specific product for Argentina or the MERCOSUR region, contact the GRZAN regulatory team at info@grzanglobal.com.